The effects of the Dramatherapeutic Self-concept Module for clients with a personality disorder. (De werking van de Dramatherapeutische Zelfbeeldmodule bij cliënten met een persoonlijkheidsstoornis)

The effects of the Dramatherapeutic Self-concept Module: a multiple baseline single-case study on the effects of the Dramatherapeutic Self-esteem Module for patients with a personality disorder, who are indicated for outpatient schemafocused therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22201

Enrollment

Registered

2018-05-30

Start date

2019-02-18

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

self-esteem (zelfwaardering) personality disorders (persoonlijkheidsstoornissen) dramatherapy (dramatherapie)

Interventions

The DZM, an intervention of 6 weekly sessions of 75 minutes each in a group van 6 participants, lead by a drama therapist. In this module clients work on enhancing their self-esteem by means of bahavi

Eligibility

Inclusion criteria

Inclusion criteria: - a low self-esteem (score RSES =27) - a personality disorder as main diagnosis DSM-5 - being able and willing to participate in a group treatment - being assessed to outpatient schema focused therapy - being in treatment phase 1 of this therapy. This is the phase before the schema focused therapy, which takes place in phase 2.

Exclusion criteria

Exclusion criteria: - acute suicidality - mentally disabled - serious agressive behaviour - serious addiction(s) - clients with a Cluster A-personality disorder or with an antisocial personality disorder.

Design outcomes

Primary

Measure	Time frame
Change in self-esteem, weekly measured before, during and after the intervention (DZM).	—

Secondary

Measure	Time frame
Change in well-being, weekly measured before, during and after the intervention (DZM).	—

Contacts

Public ContactM. Mulder

Mediant GGZ

mh.mulder@mediant.nl088-3736700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)